rs10740051
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001145263.2(NCOA4):c.-15+4856G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.247 in 152,164 control chromosomes in the GnomAD database, including 5,515 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.25 ( 5515 hom., cov: 32)
Consequence
NCOA4
NM_001145263.2 intron
NM_001145263.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.526
Publications
29 publications found
Genes affected
NCOA4 (HGNC:7671): (nuclear receptor coactivator 4) This gene encodes an androgen receptor coactivator. The encoded protein interacts with the androgen receptor in a ligand-dependent manner to enhance its transcriptional activity. Chromosomal translocations between this gene and the ret tyrosine kinase gene, also located on chromosome 10, have been associated with papillary thyroid carcinoma. Alternatively spliced transcript variants have been described. Pseudogenes are present on chromosomes 4, 5, 10, and 14. [provided by RefSeq, Feb 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.505 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NCOA4 | NM_001145263.2 | c.-15+4856G>A | intron_variant | Intron 1 of 9 | ENST00000581486.6 | NP_001138735.1 | ||
| NCOA4 | NM_001145260.2 | c.34+1762G>A | intron_variant | Intron 2 of 11 | NP_001138732.1 | |||
| NCOA4 | NM_001145261.2 | c.34+1762G>A | intron_variant | Intron 2 of 10 | NP_001138733.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.247 AC: 37582AN: 152044Hom.: 5511 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
37582
AN:
152044
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.247 AC: 37592AN: 152164Hom.: 5515 Cov.: 32 AF XY: 0.254 AC XY: 18926AN XY: 74400 show subpopulations
GnomAD4 genome
AF:
AC:
37592
AN:
152164
Hom.:
Cov.:
32
AF XY:
AC XY:
18926
AN XY:
74400
show subpopulations
African (AFR)
AF:
AC:
4605
AN:
41516
American (AMR)
AF:
AC:
3410
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
1238
AN:
3472
East Asian (EAS)
AF:
AC:
2248
AN:
5174
South Asian (SAS)
AF:
AC:
2516
AN:
4820
European-Finnish (FIN)
AF:
AC:
2905
AN:
10588
Middle Eastern (MID)
AF:
AC:
85
AN:
294
European-Non Finnish (NFE)
AF:
AC:
19760
AN:
67984
Other (OTH)
AF:
AC:
615
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1380
2760
4139
5519
6899
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
406
812
1218
1624
2030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1554
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.